Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research
October 18, 2023 08:31 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company has...
Yield10 Bioscience Provides Update on Recent Advancements in the Development of Elite Herbicide Tolerant Camelina
October 11, 2023 08:31 ET
|
Yield10 Bioscience, Inc.
-On track for commercial launch of first herbicide tolerant Camelina variety as early as 2025 -First field tests of stacked herbicide tolerant winter Camelina underway -Recent positive field tests...
Yield10 Bioscience Completes Harvest of a Majority of the 2023 Winter and Spring Camelina Grain Grown Under Contract, Generating Revenue from Biofuel Production
October 03, 2023 08:31 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the harvest of a...
Yield10 Bioscience to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 07, 2023 08:31 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that management will...
Yield10 Bioscience Announces Closing of $3.7 Million Public Offering
August 15, 2023 13:00 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced the closing of its...
Yield10 Bioscience Announces Second Quarter 2023 Financial Results
August 14, 2023 16:01 ET
|
Yield10 Bioscience, Inc.
-Harvesting underway for contracted winter and spring Camelina acres for the biofuels market-Reported positive results in first field tests of stacked herbicide tolerant Camelina-Filed a request for...
Yield10 Bioscience Announces Pricing of $3.7 Million Public Offering
August 11, 2023 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced the pricing of its public...
Yield10 Bioscience Announces Positive Results in the First Field Test of Stacked Herbicide Tolerance Traits in Camelina, Supporting Large Acreage Production of Low-carbon Intensity Feedstock Oil for the Biofuel Market
August 02, 2023 08:35 ET
|
Yield10 Bioscience, Inc.
-Findings demonstrate a key advancement in the development of proprietary Camelina varieties tolerant to application of broadleaf weed control as well as to Group 2 soil residual herbicide chemistries...
Yield10 Bioscience Files Request for Regulatory Status Review under USDA-APHIS’s SECURE Rule Covering Elite Camelina Designed to Produce the EPA Component of Omega-3 Oil
July 26, 2023 08:40 ET
|
Yield10 Bioscience, Inc.
-Omega-3 (EPA) Camelina planted at acre-scale in US nearing maturity -Development program moving forward at a solid pace toward commercialization WOBURN, Mass., July 26, 2023 (GLOBE NEWSWIRE) --...
Yield10 Bioscience Announces First Quarter 2023 Financial Results
May 10, 2023 16:02 ET
|
Yield10 Bioscience, Inc.
Executing commercial strategy for elite Camelina in the biofuels marketMet target for 2023 contracted spring Camelina acresPermitting complete, planting underway for spring seed scale-up and field...